2 01/02/2024 31/01/2025 2025-01-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2024-02-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP SC468250 2024-02-01 2025-01-31 SC468250 2025-01-31 SC468250 2024-01-31 SC468250 2023-02-01 2024-01-31 SC468250 2024-01-31 SC468250 2023-01-31 SC468250 bus:RegisteredOffice 2024-02-01 2025-01-31 SC468250 bus:LeadAgentIfApplicable 2024-02-01 2025-01-31 SC468250 bus:Director1 2024-02-01 2025-01-31 SC468250 bus:Director2 2024-02-01 2025-01-31 SC468250 core:WithinOneYear 2025-01-31 SC468250 core:WithinOneYear 2024-01-31 SC468250 bus:Micro-entities 2024-02-01 2025-01-31 SC468250 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 SC468250 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 SC468250 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 SC468250 bus:FullAccounts 2024-02-01 2025-01-31
Company registration number: SC468250
Sympa Medical Limited
Unaudited filleted financial statements
31 January 2025
Sympa Medical Limited
Contents
Directors and other information
Accountants report
Statement of financial position and notes to the financial statements
Sympa Medical Limited
Directors and other information
Directors Andrew Beveridge
Shirley Beveridge
Company number SC468250
Registered office 8 Mitchell Street
Leven
Fife
KY8 4HJ
Accountants Paterson Boyd & Co
8 Mitchell Street
Leven
Fife
KY8 4HJ
Bankers The Royal Bank of Scotland plc
104 High Street
Biggar
ML12 6BW
Sympa Medical Limited
Report to the board of directors on the preparation of the
unaudited statutory financial statements of Sympa Medical Limited
Year ended 31 January 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Sympa Medical Limited for the year ended 31 January 2025 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of ICAS , we are subject to its ethical and other professional requirements which are detailed at http://www.icas.com/accountspreparationguidance.
This report is made solely to the board of directors of Sympa Medical Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Sympa Medical Limited and state those matters that we have agreed to state to the board of directors of Sympa Medical Limited as a body, in this report in accordance with the requirements of ICAS as detailed at http://www.icas.com/accountspreparationguidance. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Sympa Medical Limited and its board of directors as a body for our work or for this report.
It is your duty to ensure that Sympa Medical Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Sympa Medical Limited. You consider that Sympa Medical Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Sympa Medical Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Paterson Boyd & Co
Chartered Certified Accountants
8 Mitchell Street
Leven
Fife
KY8 4HJ
11 July 2025
Sympa Medical Limited
Statement of financial position
31 January 2025
2025 2024
£ £ £ £
Fixed assets 626 1,253
_______ _______
Current assets 185,400 153,341
Prepayments and accrued income 134 115
_______ _______
185,534 153,456
Creditors: amounts falling due within one year ( 20,439) ( 25,840)
_______ _______
Net current assets 165,095 127,616
_______ _______
Total assets less current liabilities 165,721 128,869
Accruals and deferred income ( 2,287) ( 799)
_______ _______
Net assets 163,434 128,070
_______ _______
Capital and reserves 163,434 128,070
_______ _______
Notes to the financial statements
Sympa Medical Limited
Year ended 31 January 2025
1. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2024: 2 ).
For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 11 July 2025 , and are signed on behalf of the board by:
Shirley Beveridge
Director
Company registration number: SC468250
The company is a private company limited by shares, registered in Scotland.